The new Medical Affairs business unit will combine Ashfield’s existing Medical Information, Pharmacovigilance and Medical Science Liaison services. The unit is being established as part of Ashfield’s five-year growth plan to provide its clients leading services across the entire healthcare value chain by investing in people, technology and infrastructure. Amy’s role will be focused on raising awareness of Ashfield’s Medical Affairs capabilities and executing the flexible and scalable programs clients require. She will be located in the Fort Washington, PA corporate headquarters of Ashfield U.S.
Commenting on the appointments and launch of the Medical Affairs business unit, Greg Flynn, President Ashfield U.S. said: “I am delighted to welcome Amy and Lee to Ashfield. Investment in talent is key to our business, and we are delighted to have these leaders with deep subject matter expertise join us. Their appointments underscore our commitment to providing best-in-class medical affairs solutions and providing our biopharmaceutical clients with seamless, end-to-end commercialisation services. We believe having one business unit, under the capable direction of Amy Van Sant, will offer our clients a much stronger and effective solution to their medical affairs issues.“
Click
here to read the whole article.